Roche To Improve Real-World Cancer Data Extraction With Flatiron Buy

Acquisition reflects that regulatory-grade real-world evidence will play increasing role in drug discovery, development, commercialization and reimbursement.

Evidence
• Source: shutterstock.com

Roche says its planned purchase of cancer data specialist Flatiron Health Inc. will help the Swiss group progress its own pipeline while helping to design the use of real-world evidence to set new industry standards for oncology research and development.

The acquisition, announced Feb. 15, stems from an existing partnership between the two companies, with Roche already holding a 12.6%...

More from Business

More from Medtech Insight